coronavirus

A first-in-human trial shows how computationally designed antigens could help shift vaccines from reactive to future-proof.

Vaxart aims to revolutionize immunization by replacing injections with easy-to-take tablets.

Therapeutics that mimic or manipulate components of mucus may protect against deadly infections.

LIVE April 19th, 2022 at 11:30 AM
Biologics targeting coronavirus and variants of interest emerge as the latest therapeutic strategy for treating COVID-19.

A naturally occurring nanoparticle yields a new type of vaccine that offers broad-acting protection against emerging SARS-CoV-2 variants. With further development, the approach may lead to a pan-coronavirus vaccine.